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Dear Editor, 
 
We read with interest findings of a genome-wide association study (GWAS) in the UK 
Biobank reported by Clarke et al1 in Molecular Psychiatry. The authors aimed to conduct a 
GWAS of alcohol consumption. Prior to conducting the GWAS, Clarke and colleagues 
regressed alcohol intake on body weight and age, and used the residuals from this 
regression analysis for the GWAS analysis. The authors identified 14 loci harbouring variants 
associated with the residuals at levels indicative of GWAS significance and took these 
forward to characterise the relationship of these SNPs with various phenotypes, such as 
adiposity. 
 
By adjusting alcohol for body weight prior to the GWAS, Clarke and colleagues in effect 
generate a phenotype which is automatically associated with body weight and its 
correlates.2 When the SNPs from the GWAS are combined (as the authors do), this would 
have the effect of generating a genetic instrument that has a positive association with 
alcohol and an inverse association with body weight. This can lead to spurious findings when 
the SNPs are then related to other traits. For example, in figure 3, the authors note a 
negative genetic correlation of alcohol consumption (indexed by SNPs associating with 
alcohol adjusted for body weight) with various markers of adiposity including waist 
circumference, body mass index, overweight and obesity. In Table 2, these relationships are 
more formally characterised: a polygenic risk score associating with 0.08 SD higher alcohol 
per week was associated with a 0.024 SD lower body mass index (BMI). A naïve 
interpretation would be that more alcohol leads to less adiposity, however this would be 
incorrect. Large-scale Mendelian randomization meta-analysis using rs1229984 in ADH1B 
has identified the genetic variant associated with more alcohol intake to be strongly 
associated with a higher (not lower) body mass index.3 A recent instrumental variable study 
that used flushing as a proxy for ALDH2 genotype also suggested strong associations of 
more alcohol with higher BMI 4. Thus, a large body of evidence using reliable Mendelian 
randomization approaches indicates that consuming more alcohol, all things being equal, 
leads to higher BMI.  
 
So why the discordance between these Mendelian randomization studies and the current 
report by Clarke and colleagues? As described above, by regressing alcohol for body weight 
prior to the GWAS, this means that SNPs that were identified by the GWAS had a pattern of 
association indicative of higher alcohol but lower body weight. In effect, the associations 
that Clarke and colleagues report with adiposity have been induced by the very nature of 
their statistical model. 
 
An analogy is conducting a GWAS for waist hip ratio (WHR) adjusted for BMI (WHRadjBMI) – 
on combining the 49 WHRadjBMI SNPs together, the SNPs collectively associate with higher 
WHR but also associate with lower BMI5, 6. This means that while the aim of deriving the 
  
WHRadjBMI phenotype was to proxy central adiposity independently of general adiposity, 
the net consequence is to derive a genetic instrument that has opposing effects of 
contrasting adiposity elements, which can introduce confounding7 and make challenging the 
interpretation of findings when taking these variants forward into the Mendelian 
randomization setting.  
 
The findings by Clarke et al1 highlight the complexities that can arise in Mendelian 
randomization analysis8. We caution against interpreting these data as suggesting that 
alcohol consumption is correlated with “many positive health and behavioural traits”. The 
burden of evidence indicates that higher alcohol consumption leads to higher levels of many 
deleterious cardiovascular risk factors including adiposity, blood pressure, inflammation 
markers, coronary calcification and vascular disease.  
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